Omega Therapeutics (OMGA) : 3-year performance

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform.

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 93
• Founded by Noubar B. Afeyan and David Berry on July 13, 2016
• Headquartered in Cambridge, Massachusetts
• https://omegatherapeutics.com

IPO: July 30, 2021 on the Nasdaq Global Select Market

Ticker: OMGA

3 months later (Feb 11, 25)